Check Point Software Technologies goes into its July 24 earnings print with a notable tension: shorts are rebuilding at the fastest pace in months, the stock has recovered most of its post-April losses, and a Raymond James downgrade landed the morning of July 15 — all before a quarter the Street still has serious reservations about.
The most striking development in the data is the pace of short repositioning. Estimated short interest has climbed 53% over the past month and rose another 20% in just the past week, reaching roughly 6.3 million shares. That is an aggressive build in a relatively short window. The context matters though: availability in the lending market remains extremely loose, with roughly 32.8 million shares available to borrow — an availability ratio above 500%, which is well into normal territory and far from any stress level. Cost to borrow is just 0.44%, and it actually eased 14% on the week. The short build looks like deliberate pre-earnings positioning rather than a borrow squeeze in the making. Put/call ratio tells a similar story: it jumped to 0.61 on July 14, versus a 20-day mean of 0.47, pushing the z-score to 1.6 — more defensive than usual but not at an extreme. Shorts and options traders are leaning cautious into the print, while the lending market gives them all the room they need.
The Street is genuinely split on what comes next, and this week's analyst moves crystallise the divide. Raymond James downgraded CHKP to Market Perform on July 15, the morning this note is filed. A week earlier, Barclays kept its Equal-Weight but lifted its target from $133 to $145 — acknowledging the stock's recovery without committing to a bull view. Those two moves bracket the cautious centre of the consensus, which sits at 22 Hold ratings and only two Outperform calls, with a mean price target of $147.54. Bulls, however, got some momentum in early July: Scotiabank upgraded to Sector Outperform with a $185 target on July 6, and Guggenheim moved to Buy with a $188 target on July 1 — both citing the longer-term cybersecurity demand story around SASE and CTEM despite the near-term go-to-market disruption. Valuation gives the bull case modest support: the trailing P/E has compressed to around 11x and EV/EBITDA sits near 9x, reasonable for a cash-generative franchise. Where the argument gets harder is on growth — the forward EPS growth factor ranks in only the 15th percentile, and the analyst recommendation differential (at the 94th percentile) reflects just how widely the Street is diverging on direction rather than a clean bullish tilt.
The last earnings print is the most important data point in the snapshot. On April 30, CHKP fell 18% in a single day and extended that to an 17% loss over five days — a reaction severe enough to drag the stock from well above $160 into the $110s before the subsequent recovery to the current $137. That April miss came with lowered revenue guidance and reflected the friction in the company's go-to-market transition. The stock has since recovered 10% over the past month, but still sits nearly 10% below the Raymond James analyst's prior Outperform thesis and roughly 8% below the consensus mean target. Peers had a stronger week: SentinelOne added nearly 10%, PANW rose 4.7%, and TENB gained 5% — making CHKP's 1.2% weekly dip look more company-specific than sector-driven.
The insider picture adds a small note of caution. The 90-day net is positive in share terms at roughly 77,000 shares, but that reflects award grants rather than open-market buying. Actual cash transactions lean the other way: the Executive Chairman sold 25,000 shares in June at around $122, a Director sold a matching 25,000 shares at $123, and a separate Director sold 25,000 shares in early June at $140. These are modest percentages of the company's float, and the insider data carries only low significance scores, but no named insider has been buying into the recovery.
With the print nine days away, the question shaping up is whether management can signal that the go-to-market disruption has stabilised — not just that cybersecurity demand is structurally strong, which few dispute. The short rebuild, the Raymond James downgrade, and the memory of an 18% one-day fall will keep the market's attention squarely on the revenue guide.
See the live data behind this article on ORTEX.
Open CHKP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
